Advanced precision modeling reveals divergent responses of hepatocellular carcinoma to combinatorial immunotherapy
Cancer Commun (Lond)
.
2023 Jun;43(6):706-710.
doi: 10.1002/cac2.12421.
Epub 2023 Apr 10.
Authors
Jinping Liu
1
,
Lan Cheng
2
,
Hilana El-Mekkoussi
1
,
Charles-Antoine Assenmacher
3
,
Michelle Y Y Lee
1
,
Danielle R Jaffe
1
,
Kaisha Garvin-Darby
1
,
Ashleigh Morgan
1
,
Elisabetta Manduchi
1
,
Jonathan Schug
1
,
Klaus H Kaestner
1
Affiliations
1
Department of Genetics and Center for Molecular Studies in Digestive and Liver Disease, University of Pennsylvania, Philadelphia, PA, USA.
2
Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
3
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
PMID:
37037491
PMCID:
PMC10259666
DOI:
10.1002/cac2.12421
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Carcinoma, Hepatocellular* / pathology
Humans
Immunotherapy
Liver Neoplasms* / pathology
Grants and funding
P30 DK019525/DK/NIDDK NIH HHS/United States
P30 DK050306/DK/NIDDK NIH HHS/United States
R01 CA249929/CA/NCI NIH HHS/United States